Bioethics Issues

The recent attention given to bioethics in numerous articles and letters to the editor has presented a compelling discussion of decision-making in the next century. Two contributors of letters, Arthur W. Galston [The Scientist, May 13, 1996, page 12] and Brian Everill [The Scientist, Sept. 2, 1996, page 12], have probed the heart of the issue; however, at times they seem caught up in disrespecting each other's credibility. Claims of psuedoquotations and skepticism about each other's definition

Written byAaron Miller
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The recent attention given to bioethics in numerous articles and letters to the editor has presented a compelling discussion of decision-making in the next century. Two contributors of letters, Arthur W. Galston [The Scientist, May 13, 1996, page 12] and Brian Everill [The Scientist, Sept. 2, 1996, page 12], have probed the heart of the issue; however, at times they seem caught up in disrespecting each other's credibility. Claims of psuedoquotations and skepticism about each other's definition of moral dilemma have bogged the discussion down in a competition of intellectual prowess.

The heart of the matter is the difference between drawing on a broad base of ethical and philosophical insight as opposed to relying on your own intuition and experience when resolving an ethical dilemma. Everill does not seem to think that a thorough study of ethics will aid in making a decision about abortion, for example. On the contrary, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies